Skip to main content
. 2019 Jul 9;19:120. doi: 10.1186/s12876-019-1038-5

Table 1.

Laboratory findings of the present patient

WBC (*109/L) Neutrophils (*109/L) RBC (*109/L) HGB (g/dL) PLT (*109/L) ALT (IU/L) AST (IU/L) Serum copper (ug/L) Serum Zinc (ug/dl) 24-h urine copper (ug)
7ya 6.9 1.35 4.66 13.7 183 324 294 NA NA 360
7y1m 6.5 1.30 5.0 12.9 194 210 158 NA NA NA
7y6m 5.1 1.18 5.1 13.4 185 36 26 NA NA NA
8y 6.1 1.24 5.3 14.5 196 43 33 NA NA NA
11y 4mb 2.1 0.09 1.6 4.7 159 31 21 127.3 530 NA
11y 10mc 1.5 0.08 1.37 4.0 191 16 17 56.3 500 30
11y 10md 2.2 0.11 2.27 6.7 251 20 18 NA NA NA
12y 2 m 4.54 2.27 5.28 11.7 225 13 22 NA NA NA

* : multiply by. a: age at initiation of zinc therapy. b: age at onset of anemia. c: age at withdrawal of zinc. d: 1 week after zinc withdrawal. y years, m months, NA not assessed